Company & Sponsor Intelligence

Emory University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials25

Recruiting6

Completed14

Countries1

Therapeutic footprint

alzheimersanxietyautismdementia_otherdepressionepilepsyparkinsonsptsdschizophreniasleep_disorders

Indexed studies

NCT02383732A Study of the Elopement Prevention and Safety Training Program
autism · United StatesNA

NCT05823532Anti-Inflammatory Challenge in Schizophrenia
schizophrenia · United StatesPHASE4

NCT07572565REPAIR Sleep Study
alzheimers · NA

NCT07194083Effectiveness- Implementation Trial of the Function-Based Elopement Treatment
autism · United StatesNA

NCT05419895Early Diagnostic Response Model (EDRM)
autism · United StatesNA

NCT01965366Dexamethasone Plus Virtual Reality Exposure Therapy for PTSD
ptsd · United StatesPHASE4

NCT02299193Online CBT-I for High Blood Pressure
sleep_disorders · United StatesNA

NCT01568528Oxytocin as Adjunctive Treatment of Schizophrenia
schizophrenia · United StatesPHASE2

NCT02421978Inflammation-Induced CNS Glutamate During Breast Cancer Treatment
dementia_other · United StatesCOMPLETED

NCT03311711Preparation for End-of-Life Decision Making in Mild Dementia
alzheimers · United StatesNA

NCT02300584Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
alzheimers · United StatesNA

NCT04710004Electrophysiological Biomarkers in MTLE Patients.
epilepsy · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →